Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Eva Fortea Verdejo's Stock Ratings
Wells Fargo Analyst
Eva Fortea Verdejo is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Overall Average Return
-23.7%
Smart Score
Overall Average Return Percentile
10th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/29/2025 | ITOS | Buy Now | ITeos Therapeutics | $7.20 | 122.22% | Eva Fortea Verdejo29% | $17 → $16 | Maintains | Overweight | Get Alert |
| 04/17/2025 | BCAX | Buy Now | Bicara Therapeutics | $14.88 | -46.24% | Eva Fortea Verdejo29% | → $8 | Initiates | → Underweight | Get Alert |
| 03/06/2025 | ITOS | Buy Now | ITeos Therapeutics | $7.20 | 136.11% | Eva Fortea Verdejo29% | $19 → $17 | Maintains | Overweight | Get Alert |
| 02/28/2025 | XNCR | Buy Now | Xencor | $10.94 | 201.65% | Eva Fortea Verdejo29% | $37 → $33 | Maintains | Overweight | Get Alert |
| 12/19/2024 | ITOS | Buy Now | ITeos Therapeutics | $7.20 | 163.89% | Eva Fortea Verdejo29% | $31 → $19 | Maintains | Overweight | Get Alert |
| 12/12/2024 | XNCR | Buy Now | Xencor | $10.94 | 238.21% | Eva Fortea Verdejo29% | → $37 | Initiates | → Overweight | Get Alert |
| 10/08/2024 | RCUS | Buy Now | Arcus Biosciences | $8.75 | 231.43% | Eva Fortea Verdejo29% | → $29 | Initiates | → Overweight | Get Alert |
| 08/13/2024 | ITOS | Buy Now | ITeos Therapeutics | $7.20 | 330.56% | Eva Fortea Verdejo29% | → $31 | Initiates | → Overweight | Get Alert |
| 05/03/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $26.80 | 26.87% | Eva Fortea Verdejo29% | → $34 | Initiates | → Overweight | Get Alert |
